BRCA1 and neoplasm: Allele frequency evaluated in tumor tissue ranged from 6.4% to 89.8%, with 6.4% to 89.8% for germline BRCA1/2 wild-type patients compared to 49.9% to 88.8% for germline BRCA1/2 mutated patients.